Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects
出版年份 2021 全文链接
标题
Pharmacological inhibitors of anaplastic lymphoma kinase (ALK) induce immunogenic cell death through on-target effects
作者
关键词
-
出版物
Cell Death & Disease
Volume 12, Issue 8, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-07-16
DOI
10.1038/s41419-021-03997-x
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Gasdermin E suppresses tumour growth by activating anti-tumour immunity
- (2020) Zhibin Zhang et al. NATURE
- Immunomodulation by targeted anticancer agents
- (2020) Giulia Petroni et al. CANCER CELL
- FDA Approval Summary: Lurbinectedin for the Treatment of Metastatic Small Cell Lung Cancer
- (2020) Sonia Singh et al. CLINICAL CANCER RESEARCH
- Crizotinib-induced immunogenic cell death in non-small cell lung cancer
- (2019) Peng Liu et al. Nature Communications
- Immunosuppression by Mutated Calreticulin Released from Malignant Cells
- (2019) Peng Liu et al. MOLECULAR CELL
- Calreticulin exposure correlates with robust adaptive antitumor immunity and favorable prognosis in ovarian carcinoma patients
- (2019) Lenka Kasikova et al. Journal for ImmunoTherapy of Cancer
- Prevalent Homozygous Deletions of Type I Interferon and Defensin Genes in Human Cancers Associate with Immunotherapy Resistance
- (2018) Zhenqing Ye et al. CLINICAL CANCER RESEARCH
- Pembrolizumab plus Chemotherapy in Metastatic Non–Small-Cell Lung Cancer
- (2018) Leena Gandhi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
- (2018) Samuel Y. Ng et al. Nature Communications
- TumGrowth: An open-access web tool for the statistical analysis of tumor growth curves
- (2018) David P. Enot et al. OncoImmunology
- Wiskott–Aldrich syndrome protein (WASP) is a tumor suppressor in T cell lymphoma
- (2018) Matteo Menotti et al. NATURE MEDICINE
- Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
- (2018) Peter Schmid et al. NEW ENGLAND JOURNAL OF MEDICINE
- FDA Approval Summary: Nivolumab for the Treatment of Relapsed or Progressive Classical Hodgkin Lymphoma
- (2017) Yvette L. Kasamon et al. ONCOLOGIST
- Efficacy of nivolumab in a patient with systemic refractory ALK+ anaplastic large cell lymphoma
- (2017) Charlotte Rigaud et al. PEDIATRIC BLOOD & CANCER
- Nivolumab for Refractory Anaplastic Large Cell Lymphoma: A Case Report
- (2016) Holger Hebart et al. ANNALS OF INTERNAL MEDICINE
- The role of the ALK receptor in cancer biology
- (2016) B. Hallberg et al. ANNALS OF ONCOLOGY
- Calreticulin exposure by malignant blasts correlates with robust anticancer immunity and improved clinical outcome in AML patients
- (2016) J. Fucikova et al. BLOOD
- Caloric Restriction Mimetics Enhance Anticancer Immunosurveillance
- (2016) Federico Pietrocola et al. CANCER CELL
- Calreticulin Expression in Human Non–Small Cell Lung Cancers Correlates with Increased Accumulation of Antitumor Immune Cells and Favorable Prognosis
- (2016) Jitka Fucikova et al. CANCER RESEARCH
- Comparative Efficacy of Ceritinib and Crizotinib as Initial ALK –Targeted Therapies in Previously Treated Advanced NSCLC: An Adjusted Comparison with External Controls
- (2016) Daniel Shao-Weng Tan et al. Journal of Thoracic Oncology
- Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation
- (2016) Thomas Welte et al. NATURE CELL BIOLOGY
- Immunological off-target effects of imatinib
- (2016) Laurence Zitvogel et al. Nature Reviews Clinical Oncology
- Vaccination with Necroptotic Cancer Cells Induces Efficient Anti-tumor Immunity
- (2016) Tania Løve Aaes et al. Cell Reports
- Innate Immune Recognition of Cancer
- (2015) Seng-Ryong Woo et al. Annual Review of Immunology
- Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
- (2015) Lorenzo Galluzzi et al. CANCER CELL
- PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
- (2015) Stephen M. Ansell et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma
- (2015) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma
- (2015) S. D. Bradley et al. Cancer Immunology Research
- High Expression of Ecto-Nucleotidases CD39 and CD73 in Human Endometrial Tumors
- (2014) Elisabet Aliagas et al. MEDIATORS OF INFLAMMATION
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- Consensus guidelines for the detection of immunogenic cell death
- (2014) Oliver Kepp et al. OncoImmunology
- Autophagy-dependent ATP release from dying cells via lysosomal exocytosis
- (2013) Yidan Wang et al. Autophagy
- Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors
- (2013) S. Rusakiewicz et al. CANCER RESEARCH
- Defective immunogenic cell death of HMGB1-deficient tumors: compensatory therapy with TLR4 agonists
- (2013) T Yamazaki et al. CELL DEATH AND DIFFERENTIATION
- Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
- (2013) Yuting Ma et al. IMMUNITY
- Crizotinib-Resistant NPM-ALK Mutants Confer Differential Sensitivity to Unrelated Alk Inhibitors
- (2012) M. Ceccon et al. MOLECULAR CANCER RESEARCH
- Evolution of the cancer genome
- (2012) Ondrej Podlaha et al. TRENDS IN GENETICS
- The immuno-oncology framework
- (2012) Axel Hoos et al. OncoImmunology
- Natural Innate and Adaptive Immunity to Cancer
- (2011) Matthew D. Vesely et al. Annual Review of Immunology
- Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors
- (2011) Nicolas F Delahaye et al. NATURE MEDICINE
- Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
- (2011) Vinod P Balachandran et al. NATURE MEDICINE
- Correlation of the autoantibody response to the ALK oncoantigen in pediatric anaplastic lymphoma kinase-positive anaplastic large cell lymphoma with tumor dissemination and relapse risk
- (2010) K. Ait-Tahar et al. BLOOD
- Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
- (2010) F. Stephen Hodi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancer
- (2010) Rui-Qing Peng WORLD JOURNAL OF GASTROENTEROLOGY
- Immunogenic death of colon cancer cells treated with oxaliplatin
- (2009) A Tesniere et al. ONCOGENE
- The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination
- (2008) Roberto Chiarle et al. NATURE MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now